Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase I comparability of recombinant human albumin and human serum albumin.
Bosse D, Praus M, Kiessling P, Nyman L, Andresen C, Waters J, Schindel F. Bosse D, et al. Among authors: praus m. J Clin Pharmacol. 2005 Jan;45(1):57-67. doi: 10.1177/0091270004269646. J Clin Pharmacol. 2005. PMID: 15601806 Clinical Trial.
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.
Keitel W, Groth N, Lattanzi M, Praus M, Hilbert AK, Borkowski A, Tsai TF. Keitel W, et al. Among authors: praus m. Vaccine. 2010 Jan 8;28(3):840-8. doi: 10.1016/j.vaccine.2009.10.019. Epub 2009 Oct 14. Vaccine. 2010. PMID: 19835829 Clinical Trial.
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.
Stephenson I, Nicholson KG, Hoschler K, Zambon MC, Hancock K, DeVos J, Katz JM, Praus M, Banzhoff A. Stephenson I, et al. Among authors: praus m. N Engl J Med. 2008 Oct 9;359(15):1631-3. doi: 10.1056/NEJMc0805274. N Engl J Med. 2008. PMID: 18843132 No abstract available.
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
Galli G, Hancock K, Hoschler K, DeVos J, Praus M, Bardelli M, Malzone C, Castellino F, Gentile C, McNally T, Del Giudice G, Banzhoff A, Brauer V, Montomoli E, Zambon M, Katz J, Nicholson K, Stephenson I. Galli G, et al. Among authors: praus m. Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7. doi: 10.1073/pnas.0903181106. Epub 2009 Apr 27. Proc Natl Acad Sci U S A. 2009. PMID: 19416838 Free PMC article. Clinical Trial.
Alert systems for post-marketing surveillance of adverse drug reactions.
Praus M, Schindel F, Fescharek R, Schwarz S. Praus M, et al. Stat Med. 1993 Dec 30;12(24):2383-93. doi: 10.1002/sim.4780122414. Stat Med. 1993. PMID: 8134741
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ; PATH study group. van Schaik IN, et al. Among authors: praus m. Lancet Neurol. 2018 Jan;17(1):35-46. doi: 10.1016/S1474-4422(17)30378-2. Epub 2017 Nov 6. Lancet Neurol. 2018. PMID: 29122523 Free article. Clinical Trial.
Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency.
Rojavin MA, Chapdelaine H, Tortorici MA, Praus M, Baheti G, Zhang Y, Hofmann J, Labrosse R, Dicaire R, Haddad E. Rojavin MA, et al. Among authors: praus m. Clin Pharmacol Drug Dev. 2020 Aug;9(6):664-670. doi: 10.1002/cpdd.753. Epub 2019 Dec 8. Clin Pharmacol Drug Dev. 2020. PMID: 31814328
24 results
Jump to page
Feedback